drugs.com vs lilly.com
Market traction comparison · Updated Jul 2026
| drugs.com | lilly.com | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 5.2M | drugs.com |
| Bounce Rate | 58.5% | 54.7% | lilly.com |
| SEO & Keywords | 30 | 30 | Tie |
| Domain Age | 27y 8m | 35y 4m | lilly.com |
lilly.com leads in 2 of 4 dimensions, while drugs.com leads in 1.
Growth Momentum
| drugs.com | lilly.com | Leads | |
|---|---|---|---|
| Monthly Visits | 18.9M | 5.2M | drugs.com |
| MoM Change | +11% | -7% | drugs.com |
| Avg. Session | 1m56s | 2m14s | lilly.com |
| Pages / Visit | 2.4 | 2.8 | lilly.com |
Growth Momentum · Insight
lilly.com is losing traffic (-7%) despite 5.2M monthly visits. drugs.com's +11% growth puts it on a trajectory to overtake.
Acquisition Strategy
| drugs.com | lilly.com | Leads | |
|---|---|---|---|
| Primary Channel | Search 69% | Search 50% | |
| Bounce Rate | 58.5% | 54.7% | lilly.com |
| SEO & Keywords | 30 | 30 | — |
Keyword Overlap Rate: 43%
Acquisition Strategy · Insight
drugs.com acquires users primarily through Search (69%), while lilly.com relies on Search (50%). This reflects fundamentally different go-to-market strategies — lilly.com's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
Business Maturity
| drugs.com | lilly.com | Leads | |
|---|---|---|---|
| Domain Age | 27y 8m | 35y 4m | lilly.com |
| Registered | Dec 1998 | May 1991 | |
| Expires | Dec 2026 | May 2026 |
Business Maturity · Insight
lilly.com has been in the market for over a decade, indicating established presence.
Market Position
| drugs.com | lilly.com | Leads | |
|---|---|---|---|
| Global Rank | #3.4K | #11.6K | drugs.com |
| Category Rank | #3 | #70 | drugs.com |
drugs.com only
lilly.com only
Market Position · Insight
Each has untapped markets the other serves: drugs.com could expand into Japan, Mexico, while lilly.com could target United Kingdom, Colombia.
Key Takeaways
- •lilly.com is losing traffic (-7%) despite 5.2M monthly visits. drugs.com's +11% growth puts it on a trajectory to overtake.
- •drugs.com acquires users primarily through Search (69%), while lilly.com relies on Search (50%). This reflects fundamentally different go-to-market strategies — lilly.com's higher direct traffic suggests stronger brand recognition or product-led growth, while drugs.com's search reliance means growth is more scalable but more vulnerable to algorithm changes.
- •drugs.com receives 3.6x more monthly traffic than lilly.com (18.9M vs 5.2M).
- •drugs.com is growing (+11%) while lilly.com is declining (-7%).
- •They share 18 keywords (43% overlap), indicating direct search competition.
- •lilly.com has a 8-year head start in the market.
You've seen the gap. Now steal the playbook.
A Growth Teardown reverse-engineers exactly how each product grows — traffic sources, backlink strategy, keyword gaps, and scored action items you can copy this week.
Related Comparisons
Report based on data from July 2026